about
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.De novo thrombotic microangiopathy after non-renal solid organ transplantation.A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.Clostridium difficile colitis after kidney and kidney-pancreas transplantation.Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.The histology of kidney transplant failure: a long-term follow-up study.Recent advances and future prospects in intestinal and multi-visceral transplantation.Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.The impact of liver transplantation after surgical treatment of hepatocellular carcinomaIntra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationTolerogenic protocols for intestinal transplantation.The Efficacy of Noble Gases in the Attenuation of Ischemia Reperfusion Injury: A Systematic Review and Meta-Analyses.Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERALiver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in RatsTelomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort studySimultaneous liver kidney transplantation and (bilateral) nephrectomy through a midline is feasible and safe in polycystic diseaseSirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation.Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study.Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.Acute femoral neuropathy: a rare complication after renal transplantation.Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.Graft quality assessment in kidney transplantation: not an exact science yet!Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells?Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature.Hypothermic machine perfusion of kidneys retrieved from standard and high-risk donors.Graft rinse prior to reperfusion in liver transplantation: literature review and online survey within the Eurotransplant community.Autophagy and the Kidney: Implications for Ischemia-Reperfusion Injury and Therapy.The influence of functional warm ischemia time on DCD liver transplant recipients' outcomes.The role of osmotic self-inflatable tissue expanders in intestinal transplant candidates.The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications.Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results."Model for Early Allograft Function" Outperforms "Early Allograft Dysfunction" as a Predictor of Transplant Survival.Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.Adult Liver Allocation in Eurotransplant.Budd-Chiari syndrome: reassessment of a step-wise treatment strategy.
P50
Q30235146-C7C9CABB-A5B6-4D07-AC18-69037B99EB5AQ33417893-6F6A3126-2FE6-4C94-99EC-9EC270C9AC6EQ33575450-903AB2B3-B2EF-494F-9CEA-89F261963E5BQ33732202-02285AA7-B61D-4ABB-8E1E-9677AF3F8465Q34136980-3FD0D94C-509F-4A85-A338-907534AFFB4EQ34439824-8131D5D0-3B3B-4B5D-9EE9-85DCA95A348BQ34459649-BFAE1886-1A9B-413D-85FD-DE2C939CF625Q34483895-B61AFE32-077F-4AC8-A482-8CBA4D46ABDFQ34788255-98BDB49B-D727-4717-BA5B-9597FC34A2B7Q34868567-1A558964-F2ED-4924-87ED-3AFC22585BE2Q35640630-E82E712E-48C0-42FB-8905-A410B8FC5E10Q35893659-608337EC-8F8B-45B1-BE51-F7C129628724Q35987438-F0E7CEFD-8930-4D26-89B0-7AB38DE68610Q36111038-515148C7-49E1-4BA6-8C2D-3E31BD2AF53AQ36173974-F64ABC03-CE23-4165-8A2E-1CA67F2A1112Q36242886-5841F569-02EE-46EB-B30A-2C4312924978Q36260230-02F8215E-2A2E-4F8D-A08D-9B7F13B5DB92Q36312144-D01E7A2D-395D-4C54-B6F1-273D75A5E2EEQ36381360-4720B146-26A4-4AD8-AEF6-7ECA917BED23Q36805870-BB9254DC-BAAB-4538-A729-3F5B743412B5Q37165459-C502070F-697F-4753-8EE3-79D995539778Q37257388-89624F83-BA7C-4C1E-9535-908FE7EE20C3Q37658691-1914F1FF-FA53-492C-AD5D-8C91D1DA8F22Q37816551-22AA3B4F-6AE6-486C-BE00-D9DFD5DA03E9Q37822151-6F91C80A-838C-47F7-92A1-95D3C8161E2EQ37845384-7560E37C-2BC0-4B12-8591-0E4325B23AC5Q37850661-0398A1BE-0BBE-47D9-83A8-FF68FD3FF1BEQ38068758-A248B16C-8C42-4FC6-A42C-226E803A00D5Q38091725-9D44073A-4B1B-41F1-AD42-9C45295BA83FQ38335659-E2E2EC0B-6655-45EB-ACE2-01DA20BD93E0Q38543117-2B8C7E91-5C3E-488E-A2D1-2C8D0EE8AA66Q38546316-7ABC95B6-A6BF-4972-BAD0-0185FA7BCFE9Q38643796-51BE1BA2-5E5B-4F98-81FF-3FEC5BB724FBQ38914539-C5F84085-2F11-49D5-91BE-EAA3E1AEB9E2Q38967650-0A4FA7C4-3536-473E-8898-30142BB587B5Q40051141-E2D620CD-CCEB-49C2-91BA-FE3D1CE425F6Q40180702-4DBAE543-3DBE-4093-981C-A70B445711C2Q40330334-06610D15-6D62-4E0B-9CD5-9AE992DA7CF6Q40392744-7BD0F34F-0901-4139-A3FA-0C78CAC80F5AQ40453350-97CF9452-76A6-4FC8-B5A8-B1B8C1D2F13E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jacques Pirenne
@ast
Jacques Pirenne
@en
Jacques Pirenne
@es
Jacques Pirenne
@nl
type
label
Jacques Pirenne
@ast
Jacques Pirenne
@en
Jacques Pirenne
@es
Jacques Pirenne
@nl
prefLabel
Jacques Pirenne
@ast
Jacques Pirenne
@en
Jacques Pirenne
@es
Jacques Pirenne
@nl
P106
P21
P31
P496
0000-0002-8147-8801